Genentech Reports Positive Phase II Results for Petrelintide, an Amylin Analog for Overweight and Obesity Genentech, a member of the Roche Group today announced positive topline results from the Phase II ZUPREME-1 trial evaluating the investigational drug petrelintide versus placebo…
Missouri Court Grants Preliminary Approval for Roundup™ Class Settlement to Address Current and Future Claims A judge in the Circuit Court of the City of St. Louis, Missouri has granted preliminary approval for a proposed class action settlement aimed at…
The Fiber Broadband Association (FBA) has released a new thematic paper titled “Fiber is Player #1 for Streaming and Gaming,” examining how streaming, online gaming, and emerging immersive technologies are redefining broadband performance requirements. The report argues that fiber broadband…
Bolt Projects Holdings, Inc. Announces Voluntary Delisting from Nasdaq and SEC Deregistration Bolt Projects Holdings, Inc. (OTC Pink: BSLK, BSLKW), a leading developer of innovative biomaterials for the beauty and personal care industry, today announced that its Board of Directors…
CVR Partners Reports Q4 and Full-Year 2025 Financial Results Fourth Quarter 2025 Highlights For Q4 2025, CVR Partners reported a net loss of $10 million, or $0.97 per common unit, compared with net income of $18 million, or $1.73 per…
CMC Regulatory Requirements for Biological Drug Products Training Course Online Event: April 23–24, 2026 ResearchAndMarkets.com has added the “Chemistry, Manufacture and Control (CMC) – Regulatory Requirements for Biological Drug Products” training course to its offerings. This course is designed to…
Netherlands to Classify Marine Ucome as Fossil Fuel Under New RED Rules The Dutch Emissions Authority (NEa) has confirmed that used cooking oil methyl ester (Ucome) will be treated as a fossil fuel when supplied to the maritime sector under…
Australia Pushes for Country-Specific Carbon Rating to Boost Canola Competitiveness Australia’s canola industry is calling for a national carbon intensity (CI) rating to ensure local growers are not disadvantaged under the global Carbon Offsetting and Reduction Scheme for International Aviation…
Zoetis Receives EU Approval for Portela® (relfovetmab), the First Three-Month Monoclonal Antibody Therapy for Osteoarthritis Pain in Cats Zoetis Inc. (NYSE: ZTS), the world leader in animal health, today annonced that the European Commission has granted marketing authorization for Portela®…